Literature DB >> 877166

[Hemostatic processes in aneurysmal hemorrhages].

P Hindersin, R Heidrich.   

Abstract

Pathogenetic, diagnostic, and therapeutic problems and questions associated with ruptured cerebral aneurysms assume good knowledge of hemostatic processes. The three factors affecting hemostasia, namely, vasoactive, coagulative, and fibrinolytic risk factors in the blood, cerebro--spinal fluid, and at the site of damage to the vessel wall, are discussed withparticular reference to a thrombosing aneurysm. In the case of secondary hemorrhages it is necessary to determine the cause or pathogenesis, respectively, of the disturbance of coagulation or increase in fibrinolysis in order to be able to take suitable therapeutic measures and reduce the risk of secondary bleeding occurring within the first critical weeks after aneurysmal rupture.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 877166

Source DB:  PubMed          Journal:  Psychiatr Neurol Med Psychol (Leipz)        ISSN: 0033-2739


  2 in total

Review 1.  Clinical pharmacokinetics of cerebrospinal fluid.

Authors:  M Bonati; J Kanto; G Tognoni
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

2.  Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid.

Authors:  R Heidrich; F Markwardt; S Endler; P Hindersin
Journal:  J Neurol       Date:  1978-09-12       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.